Yoder Stephen S.

Avg. Two Year Performance

240% Avg. Purchase Return

84% Compound

No sale track record

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	3%	(5%)	(5%)	160%	240%
Purchase Success Rate	1 of 1	0 of 1	0 of 1	1 of 1	1 of 1
Average Sale Return	--	--	--	--	--
Sale Success Rate	--	--	--	--	--

Pieris Pharmaceuticals, Inc.

Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 6.0K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--